The Economist asks
Before 1 October 2017, will the FDA approve the sale of a gene-therapy treatment for inherited diseases?
Congress passed the 21st Century Cures Act in December 2016, meant to accelerate the discovery, development, and delivery of new cures (US Congress). Spark Therapeutics could become the first company to receive FDA approval to sell a gene-therapy treatment in the U.S. (The Economist, Technology Review, FDA Cellular Gene Therapy Products, Nature Journal, FDA Development Approval Process).
If you liked this question, you might also enjoy forecasting on whether the US will enact a soda tax in 2017 or on whether the FAA will grant Amazon a waiver to begin testing UAV delivery systems.